CompletedPhase 2NCT01807598
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jason Robert Gotlib
- Principal Investigator
- Jason Gotlib, M.D., M.SStanford University Hospitals and Clinics
- Intervention
- Brentuximab vedotin(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2017
Study locations (2)
- Stanford University, School of Medicine, Stanford, California, United States
- MD Anderson Cancer Center, Houston, Texas, United States
Collaborators
Seagen Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01807598 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.